GlobeNewswire Inc | Sep 22, 2021 07:00AM EDT

September 22, 2021

MENLO PARK, Calif., and SINGAPORE, Sept. 22, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced Dr Carl Firth, CEO, is scheduled to give a company presentation at the 2021 Cantor Virtual Global Healthcare Conference on September 30, 2021, at 9:20am ET. The conference will be held from September 27 to September 30, 2021.

A live webcast of the presentation will be available on September 30 at 9:20am ET and a replay will be archived for 365 days. To access the webcast, go to the News & Events section in ASLANs Investor Relations website at www.ir.aslanpharma.com or the following link: https://wsw.com/webcast/cantor12/asln/2083340

Media and IR contacts

Emma Thompson Ashley R. RobinsonSpurwing Communications LifeSci Advisors, LLCTel: +65 6206 7350 Tel: +1 (617) 430-7577Email: ASLAN@spurwingcomms.com Email: arr@lifesciadvisors.com

About ASLAN PharmaceuticalsASLAN Pharmaceuticals (Nasdaq:ASLN) is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. ASLANis currently evaluatingASLAN004, apotential first-in-classantibodytargeting the IL-13 receptor,in atopic dermatitis, and ASLAN003,apotent oralinhibitorofDHODH, which is being developed forautoimmune disease.ASLAN has a team in Menlo Park, California, and in Singapore.For additional information please visitwww.aslanpharma.comor followASLANon LinkedIn.